menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

New Horizons in Managing Menopause: Managed Care Considerations for Improved Outcomes

Game on! Test yourself on vasomotor symptoms, from risk factors to management with current and novel treatments, including selective NK3R antagonists.

Live Broadcast
1.50 available credits
Information
March 30, 2022
06:30 PM - 08:00 PM CDT
ReachMD Healthcare Image
Details
Presenters
Related
Comments
  • Overview

    Join us for a live symposium that borrows a popular game show format to test your vasomotor symptom (VMS) management skills. As you play, our expert faculty will offer guidance, context, and recommendations for the medical management of VMS beyond estrogen. Nonhormonal treatment options are currently being studied and represent a new horizon for patients and payors. Play along to make sure you’re up to date!

    Please see when the Live Broadcast will begin in your timezone:
    • 7:30 PM ET
    • 6:30 PM CT
    • 5:30 PM MT
    • 4:30 PM PT
  • Program Schedule*

    Syllabus

    6:30 pm–6:35 pm

    Welcome, Introductions, Program Overview
    Jeffrey Dunn, PharmD, MBA

    6:35 pm–6:50 pm

    Round 1: Let the Game Begin!
    Health Impact and Prevalence of Menopause
    Gary Owens, MD

    6:50 pm–7:05 pm

    Round 2: Menopause Pathophysiology
    Anita L. Nelson, MD

    7:05 pm–7:20 pm

    Round 3: Hormone Therapy Risks and Benefits
    Jeffrey Dunn, PharmD, MBA

    7:20 pm–7:35 pm

    Round 4: New Horizons and Emerging Data for Non-hormonals
    Anita L. Nelson, MD

    7:35 pm–7:55 pm

    Lightning Round! Question and Answers
    All Faculty

    7:55 pm–8:00 pm

    *Subject to change

    And the Winner is…
    Jeffrey Dunn, PharmD, MBA

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Jeffrey Dunn, PharmD, MBA
    Chief Clinical Officer
    Cooperative Benefits Group (CBG)
    Salt Lake City, UT
    No relevant relationships reported.

    Gary M. Owens, MD
    Gary Owens Associates
    Ocean View, DE
    Consulting Fees: Icon, Magnolia Innovation, Octave Biosciences, Payer Sciences

    Anita L. Nelson, MD
    Professor and Chair, Obstetrics and Gynecology
    College of Osteopathic Medicine of the Pacific
    Western University of Health Science
    Ponoma, CA

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Anna Trentini has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss data on the individual and public health burden associated with VMS
    • Describe endocrinologic changes during menopause that lead to the root cause of VMS
    • Compare and contrast the risks and benefits of current treatments for VMS to address barriers to optimal medical management
    • Evaluate the latest clinical trial data on investigational agents for VMS that are nearing approval
  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live symposium activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 90 minutes of Nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    This curriculum has been approved for 1.5 contact hours .15 CEUs by Global Learning Collaborative (GLC).  GLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is JA0006235-0000-22-003-L04-P.  This learning activity is enduring based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

  • Target Audience

    This activity is designed to meet the educational needs of managed care professionals as well as health care providers who manage female patients.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Astellas.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Details
Presenters
Related
Comments
Recommended
  • Overview

    Join us for a live symposium that borrows a popular game show format to test your vasomotor symptom (VMS) management skills. As you play, our expert faculty will offer guidance, context, and recommendations for the medical management of VMS beyond estrogen. Nonhormonal treatment options are currently being studied and represent a new horizon for patients and payors. Play along to make sure you’re up to date!

    Please see when the Live Broadcast will begin in your timezone:
    • 7:30 PM ET
    • 6:30 PM CT
    • 5:30 PM MT
    • 4:30 PM PT
  • Program Schedule*

    Syllabus

    6:30 pm–6:35 pm

    Welcome, Introductions, Program Overview
    Jeffrey Dunn, PharmD, MBA

    6:35 pm–6:50 pm

    Round 1: Let the Game Begin!
    Health Impact and Prevalence of Menopause
    Gary Owens, MD

    6:50 pm–7:05 pm

    Round 2: Menopause Pathophysiology
    Anita L. Nelson, MD

    7:05 pm–7:20 pm

    Round 3: Hormone Therapy Risks and Benefits
    Jeffrey Dunn, PharmD, MBA

    7:20 pm–7:35 pm

    Round 4: New Horizons and Emerging Data for Non-hormonals
    Anita L. Nelson, MD

    7:35 pm–7:55 pm

    Lightning Round! Question and Answers
    All Faculty

    7:55 pm–8:00 pm

    *Subject to change

    And the Winner is…
    Jeffrey Dunn, PharmD, MBA

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Jeffrey Dunn, PharmD, MBA
    Chief Clinical Officer
    Cooperative Benefits Group (CBG)
    Salt Lake City, UT
    No relevant relationships reported.

    Gary M. Owens, MD
    Gary Owens Associates
    Ocean View, DE
    Consulting Fees: Icon, Magnolia Innovation, Octave Biosciences, Payer Sciences

    Anita L. Nelson, MD
    Professor and Chair, Obstetrics and Gynecology
    College of Osteopathic Medicine of the Pacific
    Western University of Health Science
    Ponoma, CA

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Anna Trentini has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss data on the individual and public health burden associated with VMS
    • Describe endocrinologic changes during menopause that lead to the root cause of VMS
    • Compare and contrast the risks and benefits of current treatments for VMS to address barriers to optimal medical management
    • Evaluate the latest clinical trial data on investigational agents for VMS that are nearing approval
  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live symposium activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 90 minutes of Nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    This curriculum has been approved for 1.5 contact hours .15 CEUs by Global Learning Collaborative (GLC).  GLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is JA0006235-0000-22-003-L04-P.  This learning activity is enduring based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

  • Target Audience

    This activity is designed to meet the educational needs of managed care professionals as well as health care providers who manage female patients.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Astellas.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Schedule5 Dec 2022